Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis

Ophthalmology

Volumn 110, Issue 3, 2003, Pages 487-492

  Leonardi, Andrea ^a,d   Jose, Peter J ^b   Zhan, Hong ^c   Calder, Virginia L ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; EOTAXIN 2; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC KERATOCONJUNCTIVITIS; ARTICLE; CELL CULTURE; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; KERATOCONJUNCTIVITIS; LACRIMAL FLUID; MALE; MUCUS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0037370528     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01767-0     Document Type: Article

References (30)

1. Leonardi A, Brun P, Tavolato M, et al. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2000;41:4175-81.
2. Metz DP, Hingorani M, Calder VL, et al. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997;100:817-24.
3. Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999;29:1214-22.
4. Leonardi A, DeFranchis G, Zancanaro F, et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999;40:3036-40.
5. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990;108:84-8.
6. Bonini S, Bonini S, Vecchione A, et al. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 1988;82:462-9.
7. Trocmé SD, Aldave AJ. The eye and the eosinophil. Surv Ophthalmol 1994;39:241-52.
8. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
9. Rothenberg ME, Ownbey R, Mehlhop PD, et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996;2:334-48.
10. Daugherty BL, Siciliano SU, DeMartino JA, et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183:2349-54.
11. Forssman U, Uguccioni M, Loetscher P, et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-6.
12. Ying S, Meng Q, Zeibecoglou K, Robinson DS, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:6321-9.
13. Teran LM, Mochizuki M, Bartels J, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-86.
14. Chung KF, Patel HJ, Fadlon EJ, et al. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. Br J Pharmacol 1999;127:1145-50.
15. Leonardi A, Borghesan F, Faggian D, et al. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000;129:151-8.
16. Trocmé SD, Kephart GM, Allansmith MR, et al. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 1989;108:57-63.
17. Trocmé SD, Hallberg CK, Gill KS, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci 1997;38:593-9.
18. Leonardi A, Radice M, Fregona IA, et al. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. Exp Eye Res 1999;68:739-46.
19. Evans CAW, Garcia HH, Hartnell A, et al. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 1998;66:4522-5.
20. Fukagawa K, Nakajima T, Tsubota K, et al. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999;103:1220-1.
21. Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol 2000;84:1360-6.
22. Dulkys Y, Schramm G, Kimmig D, et al. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol 2001;116:498-505.
23. Culley FJ, Brown A, Conroy DM, et al. Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J Immunol 2000;165:6447-53.
24. Fukagawa K, Nakajima T, Saito H, et al. IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Arch Allergy Immunol 2000;121:144-50.
25. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci 2000;41:1448-53.
26. Solomon A, Shmilowich R, Shasha D, et al. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Ophthalmol Vis Sci 2000;41:1038-44.
27. Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-γ, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000;30:103-9.
28. Leonardi A, Borghesan F, DePaoli M, et al. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. Exp Eye Res 1998;67:105-12.
29. Terada N, Hamano N, Nomura T, et al. Interleukin-13 and tumour necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 2000;30:348-55.
30. Mochizuki M, Bartels J, Mallet AI, et al. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-8.